The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial

The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial

Abstract Background Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a severe condition with high mortality due to lack of efficient therapy. Until now, the use of methylprednisolone (MP) in HBV-ACLF is still controversial. We aimed to evaluate the efficacy and safety of MP in...

Full description

Bibliographic Details
Main Authors: Lin Jia, Ran Xue, Yueke Zhu, Juan Zhao, Juan Li, Wei-Ping He, Xiao-Mei Wang, Zhong-Hui Duan, Mei-Xin Ren, Hai-Xia Liu, Hui-Chun Xing, Qing-Hua Meng
Format: Article
Language:English
Published: BMC 2020-12-01
Series:BMC Medicine
Subjects:
Hepatitis B
Acute-on-chronic liver failure
Methylprednisolone
Online Access:https://doi.org/10.1186/s12916-020-01814-4

Internet

https://doi.org/10.1186/s12916-020-01814-4

Similar Items